Literature DB >> 19577986

Anatomo-pathological analysis after CoreValve Revalving system implantation.

Stéphane Noble1, Anita Asgar, Raymond Cartier, Renu Virmani, Raoul Bonan.   

Abstract

AIMS: Significant technological improvements have made percutaneous aortic valve replacement (PAVR) simpler and safer, but the behaviour of the implanted valve over time remains unknown. We report the anatomo-pathological analysis of patients who died at different time intervals post PAVR with the CoreValve Revalving System. METHODS AND
RESULTS: In our early experience, 21 patients underwent CoreValve implantation between 12/2005 and 02/2007. Among the 11 deaths at one year follow-up, four patients had an autopsy with macro and microscopic analysis. The device was divided in three parts during pathological assessment: the lower portion (area 1), the leaflets (area 2) and the upper part (area 3). The CoreValves were implanted for 3, 13, 104 and 350 days. Gross examination showed neointimal tissue covering most of the frame struts in contact with the aortic wall, but areas of high velocity blood flow were bare. Histopathology examination demonstrated fibrin deposition and inflammatory response early after valve implantation, followed by neointimal coverage with progressive regression of the inflammatory response over time.
CONCLUSIONS: While waiting for results of longer term PAVR echocardiographic follow-up, the anatomic assessment is encouraging with neointimal coverage of the native valve site and no excessive pannus formation occurring over the valve leaflets.

Entities:  

Mesh:

Year:  2009        PMID: 19577986     DOI: 10.4244/eijv5i1a12

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  10 in total

Review 1.  Antithrombotic management after transcatheter aortic valve implantation.

Authors:  Fiachra McHugh; Khalid Ahmed; Antoinette Neylon; Faisal Sharif; Darren Mylotte
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 2.  Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Björn Plicht; Heike Hildebrandt; Polykarpos Patsalis; Karim El Chilali; Daniel Wendt; Matthias Thielmann; Lars Bergmann; Eva Kottenberg; Marc Schlamann; Holger Eggebrecht; Heinz Jakob; Gerd Heusch; Thomas Konorza; Raimund Erbel
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 3.  Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).

Authors:  Abhishek Sharma; Sunny Goel; Carl J Lavie; Armin Arbab-Zadeh; Debabrata Mukherjee; Jason Lazar
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 4.  Antiplatelet therapy in valvular and structural heart disease interventions.

Authors:  Annunziata Nusca; Edoardo Bressi; Iginio Colaiori; Marco Miglionico; Germano Di Sciascio
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

5.  Is an antithrombotic strategy after transcatheter aortic valve implantation clearer now?

Authors:  Meina Lv; Shaojun Jiang; Tingting Wu; Wenjun Chen; Jinhua Zhang
Journal:  J Thromb Thrombolysis       Date:  2021-05-24       Impact factor: 2.300

6.  Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease.

Authors:  Alexander C Fanaroff; Amit N Vora; Renato D Lopes
Journal:  Eur Heart J Suppl       Date:  2022-02-14       Impact factor: 1.803

Review 7.  Biomechanics of Transcatheter Aortic Valve Implant.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Pierluigi Nappi; Antonio Fiore
Journal:  Bioengineering (Basel)       Date:  2022-07-04

8.  Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals.

Authors:  V J Nijenhuis; P R Stella; J Baan; B R G Brueren; P P de Jaegere; P den Heijer; S H Hofma; P Kievit; T Slagboom; A F M van den Heuvel; F van der Kley; L van Garsse; K G van Houwelingen; A W J Van't Hof; J M Ten Berg
Journal:  Neth Heart J       Date:  2014-02       Impact factor: 2.380

Review 9.  Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?

Authors:  Liesbeth Rosseel; Ole De Backer; Lars Søndergaard
Journal:  Front Cardiovasc Med       Date:  2019-04-18

10.  Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies.

Authors:  Max-Paul Winter; Philipp Bartko; Felix Hofer; Martin Zbiral; Achim Burger; Bahil Ghanim; Johannes Kastner; Irene M Lang; Julia Mascherbauer; Christian Hengstenberg; Georg Goliasch
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.